Yang Liu

6PUBLICATIONS

10CO-AUTHORS

Molecular targetsPharmacogenomicsNeurology and neuromuscular diseasesBiomaterialsMedical infection agents (incl. prions)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 08, 2026

Targeting of CH25H to boost p62-dependent autophagic degradation of α-synuclein in cell and mouse models of Parkinson's disease.

|May 22, 2026

Neuroprotective effect of astrocytic dopamine Drd2 receptor on mitochondrial complex I in a mouse model of Parkinson's disease through β-arrestin2-NDUFA10 regulation.

|Feb 04, 2026

APP-C31 pathology as a target in neurodegenerative diseases.

King Chi Yip, Woon Fei Ho, Yang Liu

|Aug 28, 2025

Navigating Brain Organoid Maturation: From Benchmarking Frameworks to Multimodal Bioengineering Strategies.

Jingxiu Huang, Yingli Zhu, Jiong Tang

|Oct 28, 2023

A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer.

Xiao-Dan Lyu, Yang Liu, Jia Wang

|Aug 25, 2023

Mefloquine targets NLRP3 to reduce lipopolysaccharide-induced systemic inflammation and neural injury.

Si-Yuan Jiang, Tian Tian, Wen-Jie Li

Pageof 1

Frequent Collaborators

Renhong Du

Ming Lu

Jingxiu Huang

Yingli Zhu

Alfred Xuyang Sun

Gavin Stewart Dawe

Yao Wei

Gang Hu

Xiwei Zhang

Lei Cao

Frequent Collaborators

Renhong Du

Ming Lu

Jingxiu Huang

Yingli Zhu